Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia Source: Eur Respir J 2011; 37: 1522-1524 Year: 2011
Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001
Monitoring of Mycoplasma pneumoniae and Chlamydia pneumoniae in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001
Severe Chlamydia pneumoniae community-acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 545s Year: 2003
Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 608s Year: 2002
Pneumonia caused by Mycoplasma pneumoniae Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005
Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis Source: Eur Respir J 2007; 29: 1127-1137 Year: 2007
Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia? Source: Eur Respir J 2003; 21: 741-742 Year: 2003
Chlamidia pneumoniae and Mycoplasma pneumoniae infection of airways in patients with broncho-obstructive diseasesSource: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005
Levofloxacin resistance among streptococcus pneumoniae isolates in a chronic disease hospital Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
Antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae strains isolated from community-aquired inferior respiratory tract infections in Romania Source: Eur Respir J 2001; 18: Suppl. 33, 140s Year: 2001
Chlamydia pneumoniae and Mycoplasma pneumonia infection in children respiratory diseases Source: Virtual Congress 2021 – Acute paediatric respiratory infections Year: 2021
Levofloxacin non-susceptible streptococcus pneumoniae in community-acquired respiratory infection; prevalence and risk factors Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Haemoptysis as the initial symptom of pneumonia caused by Mycoplasma pneumoniae Source: Eur Respir J 2001; 18: Suppl. 33, 141s Year: 2001
Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways and exacerbations of bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
Treatment of patients with bronchial asthma and latent chlamydophila pneumoniae and mycoplasma pneumoniae infections by a doxycycline Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002
Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae Source: Eur Respir J 2006; 27: 1020-1025 Year: 2006
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002